Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
Holders of 5% or more of IMNN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Imunon, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Imunon, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Imunon, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 20256:29 AM ET | Ayrton Capital LLCand 2 others | 13G/A | 0.00%2.00K shares | −7.90 ppfrom 7.90%Below 5% | Jun 30, 2025 | SEC |
| Aug 12, 20255:08 PM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 4.99%1.07M shares | −0.51 ppfrom 5.50%Below 5% | Jun 30, 2025 | SEC |
| May 30, 20255:12 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 5.50%1.11M shares | New | May 28, 2025 | SEC |
| Feb 13, 20251:50 PM ET | Ayrton Capital LLCand 2 others | 13G/A | 7.90%1.25M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Imunon, Inc. shares.
No Form 144 notices for Imunon, Inc. are on file.